Orrstown Financial Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,261
Closed -$456K 119
2026
Q1
$456K Buy
7,261
+404
+6% +$32.3K 0.08% 95
2025
Q4
$654K Buy
6,857
+582
+9% +$57.1K 0.11% 86
2025
Q3
$613K Buy
6,275
+3,640
+138% +$377K 0.1% 87
2025
Q2
$283K Buy
+2,635
New +$267K 0.06% 120
2018
Q3
Sell
-73
Closed -$2K 230
2018
Q2
$2K Hold
73
﹤0.01% 265
2018
Q1
$2K Hold
73
﹤0.01% 294
2017
Q4
$2K Hold
73
﹤0.01% 289
2017
Q3
$2K Buy
+73
New +$2.02K ﹤0.01% 286

Other funds holding BSX

Orrstown Financial Services's BSX Position: Q2 2026 in Review

Orrstown Financial Services sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 7,261 shares — an estimated $456K sold.

Orrstown Financial Services first reported a position in BSX in Q3 2017 and held it in 8 quarters. The position peaked at $654K in Q4 2025. 467 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Orrstown Financial Services reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Orrstown Financial Services sold 7,261 Boston Scientific shares in Q2 2026, an estimated $456K.
  • Orrstown Financial Services first reported a position in Boston Scientific in Q3 2017 and held it in 8 quarters.
  • Orrstown Financial Services's Boston Scientific position peaked at $654K in Q4 2025.
  • 467 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Orrstown Financial Services's 13F filing for Q2 2026, filed 10 Jul 2026.